Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Health

Baptist Health Lexington, Saint Joseph East, and Baptist Health Richmond have the best value outcomes for Sepsis in Lexington, KY

Leave a comment


best value outcomes for Sepsis in Lexington, KY

“Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalization, rehospitalization, home health, nursing home, and ED costs.”


NEW YORK (PRWEB)

Dexur’s analysis of medicare claims of hospitals within a 25-mile radius of Lexington, KY, showed that Baptist Health Lexington, Saint Joseph East, and Baptist Health Richmond had the best value outcomes over a 90 day episode for Sepsis. Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. Total cost of care data helps patients make appropriate choices and helps local ACOs, such as CHI Saint Joseph Health Partners make appropriate referral choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 871: Septicemia Or Severe Sepsis Without MV>96 Hours With Major Complication Or Comorbidity, to adjust for complications and comorbidities.

Baptist Health Lexington’s total cost of care over a 90 day episode was $24,150 (for the period between July 2016 and June 2019). The index hospitalization cost was $11,358 and the average rehospitalization cost per hospitalization was $7,419. The cost per rehospitalization was at an average of $22,259. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $869.

Saint Joseph East’s total cost of care over a 90 day episode was $24,583 (for the period between July 2016 and June 2019). The index hospitalization cost was $11,338 and the average rehospitalization cost per hospitalization was $8,771. The cost per rehospitalization was at an average of $24,820. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $826.

Baptist Health Richmond’s total cost of care over a 90 day episode was $25,417 (for the period between July 2016 and June 2019). The index hospitalization cost was $11,193 and the average rehospitalization cost per hospitalization was $9,229. The cost per rehospitalization was at an average of $24,932. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $759.

Share article on social media or email:

Health: Mental Health

Meridian Senior Living Partners with Major U.S. Based Testing Laboratory to Procure COVID-19 Tests for their Communities

Leave a comment


meridian senior living logo

This is an extension of our ongoing commitment to keep our communities as safe as possible, while decreasing the risk of issues that arise from long periods of isolation, both with our residents and seniors in the towns and cities in which we operate.


Bethesda, MD (PRWEB)

National operator Meridian Senior Living has partnered with a major U.S. based testing laboratory to procure a large supply of COVID-19 tests that will allow for more frequent testing of symptomatic residents and staff, and decreased quarantine time frames for new admissions.

Meridian Senior Living operates more than 75 communities across the country and co-manages 24 communities in China. Their U.S. communities remain open and committed to serving seniors who need or want their services.

“Our collaboration with the lab and the appointment of our Medical Director is a vital pivot point in our reopening strategy. We now have the resources and medical expertise to routinely test,” says Kacy Kang, President and Chief Operating Officer of Meridian Senior Living. “This is an extension of our ongoing commitment to keep our communities as safe as possible, while decreasing the risk of issues that arise from long periods of isolation, both with our residents and seniors in the towns and cities in which we operate.”

In addition to the testing that may be required by local or state health authorities, Meridian wants to ensure they had other tests at their disposal to align with their own operational goals to reopen communities safely and in a phased approach.

In most cases, the new tests will allow for new admissions to quarantine for less time once admitted to the community, with multiple negative tests required to decrease their quarantine time from the previously enforced 14 days.

“We don’t want the 14-day quarantine to deter someone who could benefit from our communities,” said Kevin Carlin, Principal and Chief Sales Officer of Meridian Senior Living. “Our new policy is strict and thorough to keep our communities safe, while welcoming new residents who need us.”

About Meridian Senior Living:

Meridian Senior Living, a privately held company based in Bethesda, Maryland, owns and operates seniors housing communities across the country and provides operational consulting to 24 communities in China. With more than 75 communities in 21 states and more in development, Meridian is one of the largest seniors housing operators in the U.S. The company prides itself on providing the highest quality care, exceptional lifestyle programming and a distinctive dining experience for its residents. For more information on Meridian Senior Living, visit meridiansenior.com.

Share article on social media or email:

Health

Candelis, Inc. and Planmed Oy Announce Partnership

Leave a comment



NEWPORT BEACH, Calif. and HELSINKI (PRWEB)

Candelis, Inc., a leading provider of innovative and cost-effective healthcare solutions, has partnered with Planmed Oy to offer Candelis’ ImageGrid™ Mini PACS. The ImageGrid Mini solution has been validated with the Planmed Clarity™ S, Planmed Clarity™ 2D, Planmed Clarity™3D and Planmed Verity® products to provide image storage, review, and diagnosis.

Candelis’ ImageGrid Mini offers a feature-rich, robust, and cost-effective PACS on a single small footprint hardware platform. The industry-leading and innovative platform simplifies deployment, implementation, and day-to-day image storage and reading, compared to the complexities and hidden costs associated with traditional PACS systems.

The Planmed Clarity family offers advanced mammography systems with outstanding image quality and high performance. The durable and versatile systems can be used for 3D imaging, 2D screening, diagnostic examinations, and stereotactic biopsies. Planmed Verity, the original weight-bearing CT is a point-of-care extremity CBCT providing high quality 3D images with a low patient dose maximizing ergonomics and experience for the patient and user.

“ImageGrid Mini in combination with the Planmed Clarity or Verity is ideal as a mini-PACS for image acquisition, viewing, and storage in small radiology facilities and remote radiologist offices. Radiologists can use the ImageGrid Mini at home or in their office. Small specialty clinics like Obstetrics and Gynecology, Orthopedics, Cardiology, and Chiropractic will find it useful for managing all their generated images,” said Robert Van Uitert, PhD, Vice President of Marketing at Candelis.

ImageGrid Mini complements the Planmed Clarity product family and Planmed Verity to provide a competitive solution to improve patient care. ImageGrid Mini provides PACS capabilities by simply connecting the platform to a network, which will start to receive studies from any modality. IT expertise is not required, and no down time is incurred for either installation or operation. With ImageGrid Mini, managing and archiving studies from all modalities like CR, DR, Ultrasound, MRI, CT, Mammo, Floro and PET becomes easier and less costly.

“Our partnership with Planmed will increase the distribution of ImageGrid Mini globally. ImageGrid Mini is the perfect fit for bundling with Planmed’s Clarity and Verity modalities to offer image acquisition, storage, and viewing. Planmed’s solutions with ImageGrid Mini yields immediate benefits to customers by introducing a complete and advanced solution to the practice while lowering upfront costs and enhancing productivity,” added Van Uitert.

About Candelis, Inc.

Candelis, Inc. is a leading provider of innovative and cost-effective healthcare solutions to hospitals, imaging centers and top tier healthcare equipment providers like GE, Hologic, Siemens and others. With over 3700 installations globally, these solutions significantly increase practice efficiency and quality of service provided to radiologists, referring physicians and specialists. Candelis provides enterprise class image and modality management, full-featured visualization tools, seamlessly integrated workflow products, and ASTRA™ Cloud services.

About Planmed

Finnish Planmed Oy dedicates its effort to the development, manufacturing and marketing of advanced imaging equipment and accessories that provide a unique combination of image quality and ease of use for medical imaging professionals. The company offers products for mammography and orthopedic imaging that are well-known for imaging performance, user-friendliness and good ergonomics. Since 1987, Planmed systems have provided tools for healthcare professionals in over 70 countries worldwide. Planmed Oy is part of the Finnish Planmeca Group, which operates in the field of health care technology.

Media Inquiries:

Tricia Buenvenida, +1 (949) 416-0057

tricia.buenvenida@candelis.com

Share article on social media or email:

health and fitness

AsSeenOnTV.pro and Kevin Harrington’s DRTV Campaign with H2OMAX

Leave a comment



ST. PETERSBURG, Fla. (PRWEB)

Dehydration can lead to a variety of issues such as headaches, dizziness, and cramps. To fight dehydration, people often try supplements or beverages, not realizing that they could be full of synthetic chemicals or sugars. Worst of all, those expensive options are only temporary consumable solutions. For a superior, ongoing hydration solution, there’s nothing quite like H2OMAX.

H2OMAX is a glass hydration bead that can be added to water (bottled, tap, filtered, or in a pitcher) so you can experience a clinically proven boost in hydration. Embedded with natural frequency technology, an H2OMAX hydration bead works like passive antennas (not unlike a hotel card/RFID device). By affecting calcium ion activity and improving water solubility, clinical testing proved that it helps athletes maintain their hydration better.

In the case of severe dehydration, blood plasma volume drops dramatically and critically impacts necessary bodily functions. In a clinical trial, 80% of athletes who consumed H2OMAX treated water increased or maintained blood plasma volume while undergoing a strenuous 90-minute exercise in an advanced (99° F) environmental chamber. In comparison, 60% of athletes experienced a loss in plasma volume when drinking untreated water. By helping your body maintain elevated levels of blood plasma volume, H2OMAX allows you to increase your hydration, perform longer, and recover faster.

The H2OMAX Hydration bead is warranted to last for ten years, which makes it a    simple and long-term solution to help prevent dehydration. With breakthrough technology, it can repeatedly treat up to five gallons of water at a time. Drinking H2OMAX treated water will allow you to keep more water in your bloodstream for superior hydration.

“H2OMAX is for anyone who wants to fight the common causes of dehydration,” says Eric Bauchet, CEO of H2OMAX. “We’re excited to be working with AsSeenOnTV.pro and help even more people get the hydration they need, easily and affordably.”

“There is nothing like H2OMAX anywhere in the world,” says Lisa Vrancken, Executive Vice President of at AsSeenOnTV.pro. “It has amazing benefits! Once you try it, you’ll never go back.”

As part of its DRTV campaign with AsSeenOnTV.pro, H2OMAX will be appearing in 60 second spots set to air nationwide and feature the original Shark himself, Kevin Harrington. AsSeenOnTV.pro is comprised of an award-winning team of producers, writers, videographers, and editors as well as industry veterans dedicated to finding the latest, most innovative products and ideas, and putting them on the DRTV map.

About AsSeenOnTV.pro

Headquartered in South Florida, AsSeenOnTV.pro is a full-service production, branding, and marketing company that specializes in direct response television, short- and long-form commercials, and brand building. Based out of a 25,000+ sq ft, state-of-the-art studio, the company’s creative team handles every aspect of production from script to screen to airing. For nearly two decades, AsSeenOnTV.pro’s veteran staff of writers, producers, videographers, and editors has amassed more than 50 Telly Awards, thousands of prestigious clients, and over $20 million in television placements.

About Kevin Harrington

As the inventor of the infomercial, founder of As Seen on TV, and one of the original Sharks on Shark Tank, Kevin Harrington has worked with some of the world’s biggest celebrities and launched some of the best-selling DRTV campaigns in history. Since producing his first 30-minute infomercial in 1984, Harrington has been involved in over 500 product launches that have resulted in over $4 billion in sales. Now, in his latest venture with AsSeenOnTV.pro, Harrington is on the hunt for the best new products and ideas, bringing them to homes everywhere through personalized DRTV campaigns featuring the Shark.

For more information on H2OMAX, please visit http://www.H2OMAX.com.

Share article on social media or email:

Health

Telehealth, Remote Patient Monitoring Crucial to Long-Term Cardiac Health Implications of COVID-19

Leave a comment


Remote patient monitoring

“Although we’re still learning about COVID-19, it’s transformed our healthcare system’s monitoring and treatment approaches for patients,” InfoBionic CEO Stuart Long said.


WALTHAM, Mass. (PRWEB)

As concerns grow over the long-term cardiovascular health implications of COVID-19, health providers look to remote patient monitoring and telehealth to improve patient outcomes. Leading ambulatory cardiac monitoring provider InfoBionic sees a tremendous challenge ahead where thousands will deal with long-term cardiovascular health effects of COVID-19. “Although we’re still learning about COVID-19, it’s transformed our healthcare system’s monitoring and treatment approaches for patients,” InfoBionic CEO Stuart Long said. With cardiovascular injury a long-term effect for COVID-19 survivors, healthcare needs a proven means of telemetry style remote cardiac monitoring that can facilitate faster interventions that can improve health outcomes.”

Studies have shown that up to 20 percent of patients with COVID-19 may have heart injury due to coronavirus, which researchers attribute to inflammation from infection.(1) This comes at a time when a small but increasing number of cases in the US and elsewhere show that otherwise healthy people with coronavirus are suffering blood vessel injuries, blood clots, arrhythmia, strokes, and heart attacks due to excessive clotting.(2)

COVID-19 Causes, Hotspots and the Heart

A growing understanding among researchers and cardiologists is that the coronavirus appears to enter and infect the heart cells though ACE2 receptors. These receptors are prevalent in the lungs, the heart and blood vessels where the virus can lead to cell dysfunction and cellular death.(3) Current inflammation drugs used to treat the infection can also exacerbate underlying heart issues.(4)

While the most recent data shows that 20 states are classified as hotspots (i.e. increasing infection rates), healthcare must simultaneously deal with the long-term health implications of COVID-19 survivors.(5) There is a growing prevalence of reports showing the lasting heart impairments of the coronavirus and how persistent inflammation can cause chronic cardiac complications after recovery.(6)(7)

There is a new understanding of the cardiovascular dangers for young as well as older patients with and without comorbidities. These long-term health risks positions remote patient monitoring (RPM) to impact everything from sick leave and disability policies to research studies on the long-term effects of a COVID-19 aftermath.(8)

The understanding of COVID-19 and the long-term health effects of survivors and what they might need in terms of healthcare is still being studied.(9) but it’s already clear that a significant portion of the more than 2.5 million Americans who’ve contracted coronavirus may have lingering symptoms. This can be seen in the mounting stories of those who have survived COVID-19 but face ongoing health challenges, with many being heart-related conditions.(10)

Heart Monitoring and Long-term COVID Heart Health

COVID-19 complications connected to heart health may emerge and disappear. Healthcare providers will need ways to monitor the cardiovascular health of these patients remotely to curb hospital readmissions and circumvent heart issues before they become serious according to Long.

Remote cardiac monitoring and telehealth are obvious solutions to this problem as telehealth and RPM use for recovering COVID-19 patients becomes more prevalent.(11) The new reality of RPM and telehealth can be seen in the following surveys:

  • 88 percent of healthcare providers have invested in, or are evaluating, RPM technologies.(12)

  • A survey of HR executives showed that 77 percent of respondents saw telehealth as a permanent change regardless of the length of the pandemic.(13)

The reality is that monitoring a significant post-COVID-19 patient population in the long term will be a reality that requires health providers, cardiologists, and hospitals to have solutions that are simple and unobtrusive for the patient. According to Long, the implications of RPM are far reaching beyond the countless conditions associated with inflammation impacting heart health. “A major need for effective RPM will include studies impacting longer health outcomes and treatments of these conditions,” Long explained. Physicians and cardiologists will need non-invasive cardiac monitors that provide full disclosure data to deal effectively with these needs without disrupting patient lives.”

The evolution of these monitoring interventions and studies will require healthcare providers and researchers to continuously review user experience, adoption rates and resulting outcomes. This will impact future interventions, treatments and understanding of how viruses generally and COVID-19 specifically impact the body long-term. The recent update of legislation from the Food and Drug Administration allowing usage modifications in the function of RPM tools during the COVID-19 Outbreak will go a long way to changing the dynamic of long-term health outcomes.(14)

About InfoBionic:

InfoBionic is a digital health company transforming the efficiency and economics of ambulatory remote patient monitoring processes by optimizing clinical and real-world utility for the users that need it most—physicians and their patients. The Massachusetts-based team of seasoned entrepreneurs leverages successful careers in healthcare, IT, medical devices, and mobile technology, along with specific expertise in remote monitoring and cardiology. Their first-hand experience with the complexities of traditional cardiac arrhythmia detection and monitoring processes led to design of the transformative MoMe® Kardia platform to remove the roadblocks, thus amounting to a faster and more effective process for decision-making and diagnosis. InfoBionic is the recipient of the Frost & Sullivan 2019 North American Remote Cardiac Monitoring Technology Leadership Award. For more information, visit http://www.infobionic.com.

1.    Shi S, Qin M, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China, JAMA Cardiology, March 25, 2020, jamanetwork.com/journals/jamacardiology/fullarticle/2763524.

2.    Katherine Harmon Courage. “Coronavirus’s new mystery: It’s causing strokes in healthy people,” Vox, May 1, 2020, vox.com/2020/5/1/21244171/stroke-coronavirus-symptoms-blood-clots

3.    Julia Reis. “COVID-19 Can Attack the Heart in Addition to the Lungs,” Healthline, May 20, 2020, healthline.com/health-news/how-covid-19-triggers-heart-conditions

4.    Lun Wang, Yang Zhang, Shuyang Zhang. “Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy,” Frontiers in Cardiovascular Medicine, April 30, 2020. frontiersin.org/articles/10.3389/fcvm.2020.00078/full

5.    Jennifer Kates, et al. “Where are the COVID-19 Hotspots? Tracking State Outbreaks,” Kaiser Family Foundation, June 24, 2020, kff.org/coronavirus-covid-19/issue-brief/where-are-the-covid-19-hotspots-tracking-state-outbreaks/

6.    Brit Long William J. Brady, Alex Koyfman Michael Gottlieb. “Cardiovascular complications in COVID-19,” American Journal of Emergency Medicine, April 14, 2020, ajemjournal.com/action/showPdf?pii=S0735-6757%2820%2930277-1

7.    Akbarshakh Akhmerov, Eduardo Marbán. COVID-19 and the Heart, AHA Journals circulation research, April 3, 2020, ahajournals.org/doi/pdf/10.1161/CIRCRESAHA.120.317055

8.    Lisa Du. “Virus Survivors Could Suffer Severe Health Effects for Years,” Blomberg, May 12, 2020, bloomberg.com/news/articles/2020-05-12/covid-19-s-health-effects-can-last-long-after-virus-is-gone

9.    Lois Parshley. The emerging long-term complications of Covid-19, explained,” Voc, June 12, 2020, vox.com/2020/5/8/21251899/coronavirus-long-term-effects-symptoms

10.    Rick Jervis, Lindsay Schnell, Alan Gomez, and Deborah Barfield Berry. “Memory loss, gnarled fingers, panic attacks: COVID-19 didn’t kill these Americans, but many might never be the same,” USA Today, June 19, 2020, usatoday.com/in-depth/news/nation/2020/05/29/coronavirus-survivors-battle-ongoing-symptoms-might-never-same/5215914002/

11.    Kevin Joy. “How Remote Patient Monitoring Is Aiding the COVID-19 Fight,” HealthTech Magazine, June 11, 2020, healthtechmagazine.net/article/2020/06/how-remote-patient-monitoring-aiding-covid-19-fight-perfcon

12.    Samantha McGrail. “88% of Providers Investing in Remote Patient Monitoring Tech,” mHealth Intelligence, November 4, 2019, mhealthintelligence.com/news/88-of-providers-investing-in-remote-patient-monitoring-tech

13.    Rafi Musher, Mark Bremer, et al. “Forecasting the long-term impact of telemedicine,” Stax, April 20, 2020, stax.com/telemed

14.    Coronavirus (COVID-19) Update: FDA allows expanded use of devices to monitor patients’ vital signs remotely, FDA, March 20, 2020, fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-allows-expanded-use-devices-monitor-patients-vital-signs-remotely

# # #

Industry: Healthcare

NeoTract Designates Dr. Tim Davenport as UroLift® Center of Excellence

Leave a comment


News Image

“This designation recognizes Dr. Tim Davenport as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson


PLEASANTON, Calif. (PRWEB)

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Tim Davenport, M.D., The Jackson Clinic in Jackson, TN, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Davenport has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“This designation recognizes Dr. Tim Davenport as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Health

Wellbeing ‘energy practice’, Access Bars, holds live online session to combat isolation blues

Leave a comment



CHATTANOOGA, Tenn. (PRWEB)

With social distancing measures still being enforced in many parts of the world, many people are finding they are unable to partake in their usual wellbeing and personal development practices.

In fact, an early draft of a study by researchers at The University of Manchester and Swansea University has shown that social distancing has had severely negative results on the mental health of the UK population, and American experts have spoken out to confirm they expect the situation to be the same in the US.

Researcher Simon Williams said the study found “…emotional ‘losses,’ such as a loss of self-worth, loss of motivation and a loss of meaning in daily life.”

In an effort to make mental wellbeing practices available to those ready and willing to receive it, Access Bars® will be running an online Bars session with facilitator, author and speaker Brendon Watt on July 9, with thousands of virtual attendees expected to join via Zoom.

“We know that this ‘subtle energy’ practice has the ability to completely transform a person’s state of mind, and we want to make it easily accessible for those looking for relief during this time. Normally, these sessions are conducted in person by a trained facilitator, but in light of the COVID-19 crisis, we have shifted to make it possible to still receive the benefits of the practice online,” says Brendon Watt.

Access Bars® is a set of 32 points on the head which, when lightly touched, stimulate positive change in the brain, body and psyche. Developed thirty years ago by speaker and consciousness pioneer, Gary Douglas, this subtle energy practice has been rapidly gaining popularity with celebrities, elite athletes and health-seekers all over the world, due to its accessibility and gentle approach.

According to Dr. Terrie Hope PhD, DNM, CFMW, in a study published in the Journal of Energy Psychology: Theory, Research, and Treatment in November 2017, the results of one 90-minute Access Bars® session indicated a significant decrease in the severity of depression and anxiety.

Tickets for the online class are available via the Access Consciousness website (http://www.accessconsciousness.com).

About Brendon Watt

Brendon Watt is an author, speaker, entrepreneur, and life mentor. He is one of the lead facilitators of Access Consciousness®, a set of simple-yet-profound tools currently transforming lives in 176 countries. Drawing upon his transformation from a struggling tradesman and single dad to global speaker, Brendon facilitates classes and workshops all over the world empowering others to know they are not wrong, that anything is possible and that they are only one choice away from change.

Share article on social media or email:

Health

Rigaku Analytical Devices to present during Thai Industrial Pharmacist Association (TIPA) Webinar

Leave a comment


Rigaku Progeny handheld Raman analyzer

Rigaku Progeny handheld Raman analyzer

Thai Industrial Pharmacist Association (TIPA), founded in September 2011, is a non-profit organization representing members from the pharmaceutical / biopharmaceutical industry, regulatory agencies, academia and service providers.


BANGKOK (PRWEB)

Rigaku Analytical Devices, the market leader in handheld 1064nm Raman technology, will present its solution for raw material identification during a webinar hosted by the Thai Industrial Pharmacist Association (TIPA) on July 16, 2020 at 9:30am ICT / 8:30pm EDT. Crest Nanosolution Limited, a local partner of Rigaku located in Thailand, has been instrumental in setting up this event.

Thai Industrial Pharmacist Association (TIPA), founded in September 2011, is a non-profit organization representing members from the pharmaceutical / biopharmaceutical industry, regulatory agencies, academia and service providers. TIPA is also accredited from the Pharmacy Council of Thailand as an institution for continuing pharmaceutical education. TIPA plays a very important role in the field of industrial pharmacy and pharmaceutical science in Thailand by organizing various local and international conferences to promote the exchange of knowledge and research in industrial pharmacy and related fields. The association also works closely with other associations in the region and around the world.

In the session titled, “Application of Handheld Raman for Raw Material Identification and Verification,” Jill Carreiro, Global Pharmaceutical Business Development Director at Rigaku Analytical Devices, will present an overview of the role of handheld Raman spectroscopy in the pharmaceutical market and how the needs and regulations of the industry have changed globally. In addition, the implementation of the Rigaku Progeny handheld 1064nm Raman analyzer for raw material identification, at-line, and finished product quality testing will be discussed.

Pharmacists will earn 1 CPE credit for participating.

About the Rigaku Progeny 1064nm Handheld Raman Analyzer

The Progeny handheld Raman offers the proven robustness required for high-throughput raw materials testing while being uniquely versatile enough to provide the scientific answers needed for more experimental applications. Its use of 1064nm Raman spectroscopy provides less fluorescence issues that traditional handheld Raman spectrometers are susceptible to with the added benefit of scanning through packaging. This means an increase in the speed of analysis, expanded number of materials that can be measured, and improved selectivity for greater confidence.

Additional smart features available include:

  • Ergonomically angled display with large touchscreen buttons for single-hand operation

  • Built in camera / barcode scanner

  • Adjustable focus nose cone to measure through thick polymer or dark glass

  • IP-68 sealed system to minimize cross-contamination

  • Intuitive touchscreen user interface

  • Full control of analysis parameters

  • High-speed multi-function processor and on-board memory

  • Automated data backup process for confident audit trail and data integrity

  • Connect to PC/server path via USB or WiFi

  • 100% permanent file of data resides on tool

  • 21 CFR compliant firmware and sync software

The Progeny analyzer is supported by the Rigaku global sales and support distribution team, offering 24//7 Reachback support, library updates and software upgrades for the life of the analyzer.

To register for this TIPA webinar, please visit http://www.tipa.or.th. For more information on the Rigaku Progeny 1064nm handheld analyzer, please visit http://www.rigaku.com/Progeny

About Rigaku Analytical Devices

Rigaku Analytical Devices is leading with innovation to pioneer a portfolio of handheld and portable spectroscopic analyzers for use in public health and safety, scientific and academic study, recycling and reuse of metal alloys, and to ensure the quality of key metal alloy components in critical industries. We strive to deliver quality, reliability and engaged expertise to our customers with our advanced product and capabilities and are dedicated to continual product development efforts to deliver mission critical enhancements to performance and functionality and reliable, cost-effective solutions for end users. Our rugged products operate on an open architecture platform and deliver unparalleled accuracy and support for rapid lab-quality results any time, any place.

For further information, contact:

Jen Lynch

Marketing Director

Rigaku Analytical Devices

Wilmington, MA USA

Tel: +1 781-328-1024

Jen.Lynch@rigaku.com

Share article on social media or email:

Health

Trident at AIU Professor’s COVID-19 Mitigation Plan Achieves Positive Results

Leave a comment


Dr. Paul Persaud, Faculty, Trident

For a virus without a vaccine, contact tracing is one of the most effective ways to deter its spread. The importance of contact tracers during the outbreak of a communicable disease cannot be overstated. – Dr. Paul Persaud.


CYPRESS, Calif. (PRWEB)

Dr. Thakur “Paul” Persaud, a part-time faculty member in Trident at American InterContinental University’s (Trident) College of Health and Human Services, has led a proactive charge against the spread of COVID-19 as the Director of Public Health in the City of Paterson, NJ.

His leadership has helped to mitigate the spread of the virus, with Paterson’s death rate among those who have tested positive for coronavirus sitting below the state average. The New York Times and National Public Radio, among others, have taken notice of his strategy.

While there is still much to achieve, these promising results can be traced back to Dr. Persaud’s foresight. Last year the city’s infectious disease staff sat at two. Convinced of the need of expansion and additional training in order to combat communicable diseases, Dr. Persaud successfully lobbied Paterson’s mayor for a $95,000 state grant.

Today the city’s COVID Contact Tracing Team sits at 55 people, most of them performing the time-intensive, yet essential role of contact tracing. This has put Paterson ahead of its neighbors, including the nearby New York City.

“For a virus without a vaccine, contact tracing is one of the most effective ways to deter its spread,” states Dr. Persaud. “The importance of contact tracers during the outbreak of a communicable disease cannot be overstated.”

Contact tracing is the process of identifying anyone who may have come into contact with an infection person. Tracers will collect information about these individuals, test them for the virus, help the potentially infected get treated, and then in turn, identify additional people who came into contact with these additional individuals.

Dr. Persaud has been a faculty member at Trident since 2010, teaching Emergency Healthcare Logistics in Disasters, Homeland Recovery and Continuity of Operations, and Survey of Emergency and Disaster Management.

He earned a Ph.D. in Public Health, with an Epidemiology concentration, from Walden University and a Master of Public Health from Columbia University.

About Trident at American InterContinental University

Founded in 1998, Trident at American InterContinental University (Trident at AIU) is part of an online postsecondary university serving adult learners. Trident at AIU uses the EdActive™ learning approach, which employs case-based learning in an online setting to teach real-world relevant critical thinking skills designed to enhance the lives and education of students. Trident offers quality associate, bachelor’s, master’s, and doctoral degree programs and certificates, led by a qualified faculty team, over 80% of whom have doctoral degrees. Trident at AIU is regionally accredited by the Higher Learning Commission (hlcommission.org) and has more than 22,000 alumni with a military affiliation. Trident has received acknowledgements from Washington Monthly, Military Times, and Military Advanced Education & Transition for their dedication to student success. Visit http://www.trident.edu or call at (855) 290-0290 to learn more about Trident at AIU’s wide range of educational options.

Share article on social media or email:

Health

U.S. Dermatology Partners, is pleased to welcome Kyle Kaltwasser, MD to their Baytown and Clear Lake offices

Leave a comment


Board Certified Houston Dermatologist Dr. Kyle Kaltwasser

Kyle Kaltwasser, MD

“Kyle has strong academic interests in skin cancer mimickers, vasculitis, and rashes from immune modulators. He is a frequent presenter at Texas Dermatologic Society meetings,” said Aaron Joseph, MD, Fellowship Trained Mohs Surgeon, U.S. Dermatology Partners South Texas Region.


HOUSTON (PRWEB)

U.S. Dermatology Partners is excited to welcome Board-Certified Dermatologist Kyle Kaltwasser, MD to its Baytown and Clear Lake office

Dr. Kyle Kaltwasser grew up in nearby Deer Park, Texas before attending Texas A&M University where he obtained a Bachelor of Science degree in biology in 2010. He then completed his medical degree in 2015 at the University of Texas Medical Branch in Galveston where he was elected into the Alpha Omega Alpha and Gold Humanism honor societies.

Dr. Kaltwasser began his medical internship at the Houston Methodist Hospital located in the Texas Medical Center. He went on to complete his dermatology residency at the University of Texas Medical Branch in 2019. He is an active member of the Texas Dermatological Society and the American Academy of Dermatology.

Dr. Kaltwasser is married to his high school sweetheart and they have two golden retrievers. He is an avid Houston Rockets and Texas A&M football sports fan. In his free time, he enjoys traveling with his wife, staying active, reading, and cooking.

Kaltwasser will be working in our Baytown and Clear Lake offices with Drs. Chang and Williams and Kendra McCarty, P.A. “Kyle has strong academic interests in skin cancer mimickers, vasculitis, and rashes from immune modulators. He is a frequent presenter at Texas Dermatologic Society meetings,” said Aaron Joseph, MD, Fellowship Trained Mohs Surgeon for U.S. Dermatology Partners South Texas Region.

Bay Area Dermatology Associates, now U.S. Dermatology Partners was founded by Dr. Terry Williams in 1976. He was joined in 1998 by Dr. Janice Chang. The practice focus is on medical dermatology and surgical dermatology, but some select cosmetic dermatology services are provided as well. The group has provided knowledgeable and consistent dermatological care to the Clear Lake and Galveston Bay areas for more than 40 years. Contact us to schedule an appointment today with one of our board-certified dermatologists at any of our four convenient locations: Baytown, Clear Lake, Texas City, or Webster.

For more information or to schedule a new appointment, please contact the office at 832-695-3112.

About U.S. Dermatology Partners

As one of the largest physician-owned dermatology practices in the country, U.S. Dermatology Partners’ patients have access to general medical, surgical, and cosmetic skin treatments through its coordinated care network, and also benefit from the practice’s strong dermatology subspecialty thought leaders and medical advisory board. To be the best partner to its patients, U.S. Dermatology Partners is fervently focused on providing the highest level of patient-first care, and its team, therefore, includes recognized national leaders in areas such as clinical research, psoriasis, and Mohs Surgery. To learn more, visit usdermatologypartners.com.

Share article on social media or email: